Joydeep Mukherjee

Ph.D./MBA life sciences business development and strategy leader with 20+ years of experience spanning biotechnology, oncology, translational medicine, AI-enabled computational biology, molecular diagnostics, strategic partnerships, and commercialization. Experienced sourcing and evaluating business opportunities, developing pharma/biotech relationships, managing commercial pipelines, conducting market and competitive assessments, and supporting transactions from initial opportunity identification through diligence, deal structuring, negotiation, and execution. Scientific foundation includes a Ph.D. in immuno-oncology, postdoctoral research focused on the tumor microenvironment, and subsequent UCSF research in tumor biomarkers, precision oncology, and molecular diagnostics.

Direct AI/ML experience includes development of an AI-enabled immuno-oncology transcriptomic analysis pipeline. As a founding member of OncoMDx, participated in partnership development and deal execution; MBA experience includes venture diligence, valuation, term-sheet development, and negotiation through the Venture Capital Investment Competition (VCIC). Combines scientific credibility, business judgment, analytical rigor, and commercial execution to translate complex technologies into compelling partner value propositions for scientific, technical, commercial, and executive stakeholders.

Field Application and Business Development - Revvity - Northern California

Managed scientific and commercial activities across an approximately $3.5M Northern California territory serving biotechnology, pharmaceutical, academic, diagnostic, and healthcare organizations.

• Contributed approximately $1.2M in new business while supporting an active commercial opportunity pipeline exceeding $2M.
• Identified and developed new opportunities through outbound customer engagement, scientific consultation, account mapping, workflow assessment, and relationship development.
• Built relationships across major Bay Area organizations including Genentech, Gilead, UCSF, Stanford, Arc Institute, Chan Zuckerberg Biohub, Buck Institute, and emerging biotechnology companies.
• Engaged scientific and commercial stakeholders around genomics, transcriptomics, spatial biology, biomarker discovery, multi-omics, and translational research applications.
• Translated complex technology capabilities into customer-specific scientific and commercial value propositions.
• Developed multi-threaded relationships across accounts to identify new buying centers, applications, and opportunities.
• Partnered with Business Development, Sales, Product Management, Marketing, Applications, and technical teams to advance complex opportunities.
• Supported opportunity qualification, proposal development, customer evaluations, commercial strategy, and deal progression.
• Prepared and delivered scientific presentations, workshops, seminars, strategic account reviews, and executive-level customer briefings.
• Maintained disciplined CRM records, opportunity pipelines, forecasts, competitive information, and customer follow-up.
• Represented the organization at scientific meetings, conferences, and customer events.

Founding Member | Lead Scientific & Business Strategy Consultant - OncoMDx

Served as a founding member, contributing to company strategy, business development, scientific development, and commercialization of molecular oncology and precision-diagnostic capabilities.

• Identified and evaluated business-development and partnership opportunities supporting company growth.
• Participated in end-to-end deal activities, including opportunity assessment, partner discussions, scientific and commercial diligence, deal structuring, term development, negotiation, and execution.
• Worked with leadership and external stakeholders to evaluate scientific fit, strategic value, market opportunity, implementation requirements, and partnership economics.
• Supported development of proposals, business cases, partnership structures, and commercial recommendations.
• Conducted market and competitive assessments to prioritize opportunities within molecular oncology and diagnostics.
• Helped translate scientific capabilities into differentiated customer and partner value propositions.
• Coordinated scientific, technical, operational, vendor, commercial, and leadership stakeholders through implementation.
• Contributed to development and commercialization of molecular diagnostic assays and precision-oncology services.

Scientific & Business Strategy Consultant - Diacarta Inc.

Worked directly with the Chief Scientific Officer on molecular diagnostic product-development and commercialization initiatives.

• Conducted strategic market assessments across the United States, India, and UAE to identify opportunities based on unmet need, competitive dynamics, scientific feasibility, market potential, and ROI.
• Helped prioritize product-development opportunities across oncology, HPV, infectious diseases, and biomarker diagnostics.
• Synthesized scientific, market, competitive, and commercial information into recommendations for leadership.
• Developed and optimized qPCR-based diagnostic assays using multiple chemistries.
• Contributed to CRISPR-related technology initiatives.
• Helped connect scientific innovation with market opportunity and commercialization strategy.

Scientific & Strategy Consultant — AI / Immuno-Oncology - iNDX.AI

• Helped develop an AI-enabled immuno-oncology analysis pipeline using transcriptomic data.
• Worked at the interface of computational biology, oncology, biomarkers, and potential pharmaceutical applications.
• Translated computational outputs into biologically meaningful insights relevant to biomarker discovery and precision medicine.
• Contributed to strategic discussions around potential biotech/pharma use cases for AI-enabled analytical capabilities.
• Helped translate technical platform capabilities into scientifically and commercially relevant value propositions.
• Collaborated across scientific and computational disciplines to connect platform capabilities with customer needs.

Researcher / Laboratory Manager - University of California, San Francisco - San Francisco

Managed translational oncology research while managing multidisciplinary scientific programs and research operations.

• Managed personnel, budgets, procurement, infrastructure, regulatory requirements, collaborations, scientific resources, and multiple concurrent programs.
• Developed project plans, scientific strategies, milestones, and execution priorities.
• Coordinated investigators, scientists, trainees, administrators, institutional functions, vendors, and external collaborators.
• Synthesized complex scientific information into presentations, publications, funding materials, and recommendations.
• Led development and transformation of research capabilities as scientific and organizational priorities evolved.
• Managed implementation of new technologies and research platforms from strategic need through operational adoption.
• Mentored scientists, technicians, graduate students, and postdoctoral researchers.

Postdoctoral Fellow - Hospital for Sick Children, University of Toronto - Toronto

Conducted translational oncology research focused on the tumor microenvironment.

• Integrated molecular, cellular, and analytical approaches to investigate tumor biology.
• Contributed to development of advanced research capabilities supporting translational cancer studies.

Executive MBA - Strategic Operations & Innovation - California State University, East Bay

Ph.D.

• Tumor Immunology & Immunotherapy - Institute of Postgraduate Medical Education and Research (IPGMER), University of Calcutta

Postdoctoral Fellowship - Tumor Microenvironment - University of Toronto / Hospital for Sick Children

M.Sc.

• Zoology (specialization in Advanced Cytology & Genetics) - University of Calcutta